Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine in PCOS women with mild subclinical hypothyroidism
ChiCTR2000040904Phase 4Recruiting
- Sponsor
- The Third Affiliated Hospital of Guangzhou Medical University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of levothyroxine sodium in hypothyroidism and polycystic ovary syndrome (PCOS) (2 arms), sponsored by The Third Affiliated Hospital of Guangzhou Medical University. Primary endpoints: Thyroid function, Metabolic biomarkers and 3 more. Started Dec 2020; status: recruiting.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidismpolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR2000040904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040904.